TY - JOUR
T1 - Breast Cancer Early Detection
T2 - A Phased Approach to Implementation
AU - Ginsburg, Ophira
AU - Yip, Cheng Har
AU - Brooks, Ari
AU - Cabanes, Anna
AU - Caleffi, Maira
AU - Yataco, Jorge Antonio Dunstan
AU - Gyawali, Bishal
AU - McCormack, Valerie
AU - de Anderson, Myrna Mc Laughlin
AU - Mehrotra, Ravi
AU - Mohar, Alejandro
AU - Murillo, Raul
AU - Pace, Lydia E.
AU - Paskett, Electra D.
AU - Romanoff, Anya
AU - Rositch, Anne F.
AU - Scheel, John R.
AU - Schneidman, Miriam
AU - Unger-Saldaña, Karla
AU - Vanderpuye, Verna
AU - Wu, Tsu Yin
AU - Yuma, Safina
AU - Dvaladze, Allison
AU - Duggan, Catherine
AU - Anderson, Benjamin O.
N1 - Publisher Copyright:
© 2020 American Cancer Society.
PY - 2020
Y1 - 2020
N2 - When breast cancer is detected and treated early, the chances of survival are very high. However, women in many settings face complex barriers to early detection, including social, economic, geographic, and other interrelated factors, which can limit their access to timely, affordable, and effective breast health care services. Previously, the Breast Health Global Initiative (BHGI) developed resource-stratified guidelines for the early detection and diagnosis of breast cancer. In this consensus article from the sixth BHGI Global Summit held in October 2018, the authors describe phases of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease based on awareness education and technical training, history and physical examination, and accurate tissue diagnosis. The core issues address include finance and governance, which pertain to successful planning, implementation, and the iterative process of program improvement and are needed for a breast cancer early detection program to succeed in any resource setting. Examples are presented of implementation, process, and clinical outcome metrics that assist in program implementation monitoring. Country case examples are presented to highlight the challenges and opportunities of implementing successful breast cancer early detection programs, and the complex interplay of barriers and facilitators to achieving early detection for breast cancer in real-world settings are considered.
AB - When breast cancer is detected and treated early, the chances of survival are very high. However, women in many settings face complex barriers to early detection, including social, economic, geographic, and other interrelated factors, which can limit their access to timely, affordable, and effective breast health care services. Previously, the Breast Health Global Initiative (BHGI) developed resource-stratified guidelines for the early detection and diagnosis of breast cancer. In this consensus article from the sixth BHGI Global Summit held in October 2018, the authors describe phases of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease based on awareness education and technical training, history and physical examination, and accurate tissue diagnosis. The core issues address include finance and governance, which pertain to successful planning, implementation, and the iterative process of program improvement and are needed for a breast cancer early detection program to succeed in any resource setting. Examples are presented of implementation, process, and clinical outcome metrics that assist in program implementation monitoring. Country case examples are presented to highlight the challenges and opportunities of implementing successful breast cancer early detection programs, and the complex interplay of barriers and facilitators to achieving early detection for breast cancer in real-world settings are considered.
KW - breast cancer
KW - breast cancer early detection
KW - metrics
KW - phased implementation
KW - resource stratification
UR - http://www.scopus.com/inward/record.url?scp=85088786462&partnerID=8YFLogxK
U2 - 10.1002/cncr.32887
DO - 10.1002/cncr.32887
M3 - Article
C2 - 32348566
AN - SCOPUS:85088786462
SN - 0008-543X
VL - 126
SP - 2379
EP - 2393
JO - Cancer
JF - Cancer
IS - S10
ER -